The Space Between Question & Cure
George Monty interviews Dr. Deborah Mash
Highlights
Ibogaine represents a paradigm shift in addiction treatment as a single-dose, potentially curative intervention rather than substitution therapy.
Noribogaine’s pharmacology is key to understanding long-term effects and maintenance therapy possibilities.
Safety protocols are essential due to cardiac risks; medical monitoring and electrolyte management mitigate dangers.
Veterans’ experiences and legislative advocacy are critical drivers of renewed interest and funding.
Addiction’s neurobiology and comorbidities underscore the need for integrative, biopsychosocial treatment frameworks.
Plant medicine intelligence and ethnobotany offer valuable insights for modern therapeutic development.
Neurodegenerative and neurological disease applications represent promising new frontiers for Ibogaine analogs.
Public-private partnerships and payer engagement are vital for overcoming funding and commercialization barriers.
Scientific humility and patient-centered mission guide Dr. Mash’s work, emphasizing knowledge over ego.
Ladies and gentlemen, welcome back to the True Life podcast. I hope everybody’s having a beautiful day. Hope the sun is shining. Hope the birds are singing. Hope the wind is at your back. Ladies and gentlemen, Dr. Deborah C. MASH. She’s not just a scientist. She is the space between the question and the cure. A translator between the language of neurons and the speech of the sacred. For more than two decades, with the full force of the National Institute on DrugAbuse behind her, she walked a razor’s edge between chemistry and ceremony, between the morg and the miracle. ameritus professor of neurology and molecular pharmarmacology at the University of Miami, but more importantly, one of the first to say what no one else dared, that I gain, the strange plant from the equator of myth, could be the key not just to breaking addiction, but to restoring the human story. In 1993, while most of medicine still clung to the pharmaceutical dream, she brought iboain to the FDA and said,
Show less
01:43
“This belongs in the light.”
Then spent nearly a decade in St. Kitts, not on sabbatical, but in spiritual triage, guiding the desperate, the forgotten, the reborn. She discovered Noribogaine, the hidden messenger, the afterglow chemical of change, the note behind the note. And now as CEO and co-founder of Demorex, she’s leading the charge to bring this ancient medicine into the future, not as folklore, but as evidence-based deliverance. Alan Watts told us that you are an aperture through
Show less
02:14
which the universe is looking at and exploring itself. Dr. Mash built the microscope to prove it. This isn’t medicine. It’s myth rewritten in peer-reviewed journals. This isn’t just pharmarmacology. It’s the soft thunder of redemption under a lab coat. So lean in close because when Deborah speaks, you don’t just hear data. You feel the flame of a woman who walked into the dark and returned with the map. Dr. Deborah, thank you for being here today. How are you?
https://www.youtube.com/live/OaNQsrEX7Hw?si=f8qTVTouMvBTUMnD
Subscribe to Awake Events & Posts
